Trial Information

Summary: Have you been diagnosed with Multiple Sclerosis? A clinical research study for Relapsing-Remitting MS is underway in your area.

Clinical Research studies have led to significant advances in the treatment of multiple sclerosis. If you have Relapsing-Remitting Multiple Sclerosis (RRMS), you may qualify to participate in a study to determine whether a new oral investigational medication is effective in reducing relapses.

Qualified study participants may:

• Help advance clinical research
• Receive investigational medication and medical exams
• Have access to a dedicated clinical research team

Research professionals are available to discuss the study and its requirements to determine if you may qualify for participation and answer any questions you may have.  

Coordinators of the RRMS study seek participants who:

• Are 18 to 55 years old
• Have a confirmed diagnosis of Relapsing-Remitting Multiple Sclerosis
• Have had one relapse in the past 12 months

If you qualify, your participation could last approximately two years, including one study visit every four weeks.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:33:09 AM